February 4, 2011 (San Diego, California) — Results from 22 years of cases by surgeons in Melbourne, Australia, suggest that more cardiac surgeons should learn how to use the right internal thoracic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Radial artery graft conferred lower 15-year all-cause ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. NEW ORLEANS — Patients with symptomatic multivessel CAD ...

The use of bilateral internal thoracic (mammary) arteries for coronary-artery bypass grafting (CABG) may improve long-term outcomes as compared with the use of a single internal-thoracic-artery plus ...

In long-term follow-up, patients undergoing multiarterial coronary artery bypass grafting (CABG) with either a bilateral internal thoracic artery approach or a combination approach involving a single ...

Patient survival after CABG with bilateral internal thoracic artery (ITA) grafting is partially dependent on the proportion of myocardial mass supplied by the selected target vessels, according to a ...

The left internal thoracic artery is “associated with improved survival, graft patency, and freedom from cardiac events” in comparison to leg vein grafts in a procedure called coronary artery bypass ...

New clinical practice guidelines have been released that recommend expanding the use of arteries from the chest and forearm rather than using veins from the leg when performing coronary artery bypass ...

New long-term data from the CSP 474 trial offers a challenge to some of the conventional wisdom around graft choice in CABG surgery and may further the debate over recent guideline recommendations.

Background A 24-year-old man presented with previously diagnosed Marfan's syndrome. Since the age of 9 years, he had undergone eight cardiovascular procedures to treat rapidly progressive aneurysms, ...

To the Editor: In an interim analysis of the Arterial Revascularization Trial (ART) at 5 years (Dec. 29 issue), 1 Taggart et al. found no significant differences in clinical outcomes between patients ...